07971459383

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

Eleftha 440mg Multi Dose Vial

Name: Eleftha 440mg Multi Dose Vial
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 1250 INR
Availability: InStock

Price 1250 INR/ Unit

Get a Price/Quote

MOQ : 1 Unit

Eleftha 440mg Multi Dose Vial Specification

Indication
Breast cancer, Gastric cancer

Dosage Form
Injection

Salt Composition
Trastuzumab (440mg)

Feature
Multi-dose vial for intravenous use

Ingredients
Trastuzumab Lyophilized Powder, Excipients

Application
Hospital, Oncology Use

Ph Level
6.0 (approx.)

Physical Color/Texture
White to pale yellow lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
Refrigerate at 2C - 8C. Do not freeze.

Shelf Life
24 months

Prescription Required
Yes

Sterility
Sterile powder

Administration Route
IV infusion

Her2 Status Required
Yes

Batch Number Format
Printed on pack

Reconstitution Required
Yes

Diluent Included
Yes (bacteriostatic water)

MRP Visibility
On unit box

Pack Size
1 vial per box

Container Type
Glass vial

Product Code
440mg vial

Eleftha 440mg Multi Dose Vial Trade Information

Minimum Order Quantity
1 Unit

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Units Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Eleftha 440mg Multi Dose Vial

Discover the uncommon brilliance of Eleftha 440mg Multi Dose Vial-a new, first-class IV infusion solution for oncology care. Designed with advance purchase and sale flexibility in mind, this glass vial contains sterile Trastuzumab lyophilized powder for prescription use, complete with bacteriostatic water diluent. Its multi-dose form is suited for hospital settings, treating HER2-positive breast and gastric cancer. The fragrance-free, white to pale yellow powder requires reconstitution and is batch-traceable for quality assurance. Store refrigerated, with complete MRP transparency and a 24-month shelf life. Exported from India by leading suppliers, traders, and exporters.

Diverse Clinical Applications and Specific Oncology Use

Eleftha 440mg Multi Dose Vial is primarily indicated for HER2-positive breast cancer and gastric cancer, offering reliable therapy within hospital oncology protocols. Its specific usage requires the reconstitution of sterile, lyophilized powder in bacteriostatic water for IV infusion. Application media involves administration via healthcare professionals, ensuring optimal safety and efficacy for each patient. Eleftha's multi-dose nature enhances hospital inventory management by supporting multiple infusions from a single vial, thereby reducing waste and improving workflow.

Export Markets, Sample Policy, and Secure Packaging Exchange

Eleftha 440mg Multi Dose Vial is actively exchanged in major export markets, facilitated by robust order processing systems for hospital and clinical buyers. Sample policies are available upon request, enabling healthcare providers to evaluate the product before large-scale procurement. Packaging details include secure glass vials within unit boxes, marked with batch numbers for traceability, ensuring safe goods transport. Our streamlined approach to packaging and logistics guarantees product integrity and timely delivery from India to global destinations.

FAQ's of Eleftha 440mg Multi Dose Vial:

Q: How is Eleftha 440mg Multi Dose Vial administered?

A: Eleftha 440mg is administered as an intravenous (IV) infusion after reconstituting the sterile lyophilized powder with the included bacteriostatic water, under the supervision of qualified healthcare professionals.

Q: What are the specific storage requirements for this vial?

A: The vial must be refrigerated at 2C to 8C and should not be frozen. This helps maintain the sterility and efficacy of the product until its 24-month expiry date.

Q: When should Eleftha 440mg be considered for treatment?

A: It is prescribed for patients diagnosed with HER2-positive breast cancer or gastric cancer. The decision to use Eleftha should be made by an oncologist based on HER2 test results.

Q: Where is Eleftha 440mg exported from and who are the suppliers?

A: Eleftha 440mg Multi Dose Vial is exported from India by reliable exporters, traders, and suppliers specializing in hospital oncology products.

Q: What benefits does the multi-dose vial format offer?

A: The multi-dose format allows multiple infusions from a single vial, improving hospital workflow, reducing medication waste, and enhancing overall cost-effectiveness for healthcare facilities.

Q: What quality assurance features does Eleftha 440mg provide?

A: Each unit is batch numbered and MRP-marked on its packaging for traceability and transparency, ensuring that healthcare buyers can verify product authenticity and compliance.